There is still little known about the clinical findings associated with pathogenic INTS1 variants and how they cause human disease. We would be interested in learning about new patients and families affected with pathogenic variants in INTS1 or other integrator (INTS) genes to increase our knowledge of this condition and to develop patient management guidelines.